Last reviewed · How we verify
NCT03935191
Performance of the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus
trial testing Dexcom CGM System in Diabetes in 60 participants. Status unknown.
31 May 2019
Quick facts
| Lead sponsor | DexCom, Inc. |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 1 May 2019 |
| Primary completion | 31 May 2019 |
| Estimated completion | 31 May 2019 |
Drugs / interventions tested
- Dexcom CGM System
Conditions studied
- Diabetes — all drugs for Diabetes →
Sponsor
DexCom, Inc.
Who can join
18 and older, female only, with Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this prospective observational study is to establish the performance and safety of the Dexcom G6 CGM System utilized for up to a 10-day wear period in pregnant women with diabetes mellitus.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Performance of the Dexcom G6 Continuous Glucose Monitoring System in Pregnant Women with Diabetes.
Castorino K, Polsky S, O'Malley G, Levister C, et al · · 2020 · cited 52× · PMID 32324061 · DOI 10.1089/dia.2020.0085 -
Integrated Strategies to Support Diabetes Technology in Pregnancy.
Nally LM, Blanchette JE. · · 2024 · cited 3× · PMID 39208437 · DOI 10.1097/aog.0000000000005710
Verify or expand the search:
- PubMed search for NCT03935191
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dexcom CGM System
Trials testing the same drug.
- NCT04905628 — Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus · unknown
Other recruiting trials for Diabetes
Currently open trials in the same condition.
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07417865 — ECHO Diabetes FQHC · recruiting
Other DexCom, Inc. trials
Trials by the same sponsor.
- NCT06483945 — Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry) · recruiting
- NCT05746286 — Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for Dysglycemia · NA · completed
- NCT04905628 — Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus · unknown
- NCT04794478 — Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System · NA · completed
- NCT04840446 — Evaluation of Modified Adhesives With Dexcom G6 Sensor · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03935191 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by DexCom, Inc.
- Last refreshed: 2 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03935191.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing